Wellington Shields Capital Management’s CASI Pharmaceuticals CASI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-69,535
| Closed | -$115K | – | 322 |
|
|
2025
Q3 | $115K | Sell |
69,535
-21,310
| -23% | -$38K | 0.02% | 274 |
|
|
2025
Q2 | $107K | Sell |
90,845
-49
| -0.1% | -$90 | 0.02% | 266 |
|
|
2025
Q1 | $196K | Buy |
90,894
+5,059
| +6% | +$12.4K | 0.04% | 223 |
|
|
2024
Q4 | $243K | Sell |
85,835
-3,382
| -4% | -$16K | 0.04% | 215 |
|
|
2024
Q3 | $550K | Hold |
89,217
| – | – | 0.1% | 149 |
|
|
2024
Q2 | $491K | Sell |
89,217
-3,000
| -3% | -$9.32K | 0.09% | 156 |
|
|
2024
Q1 | $333K | Sell |
92,217
-40,929
| -31% | -$220K | 0.06% | 191 |
|
|
2023
Q4 | $953K | Sell |
133,146
-20,309
| -13% | -$97.7K | 0.12% | 109 |
|
|
2023
Q3 | $393K | Sell |
153,455
-25,000
| -14% | -$59.2K | 0.05% | 161 |
|
|
2023
Q2 | $446K | Sell |
178,455
-1,688
| -0.9% | -$4.54K | 0.05% | 156 |
|
|
2023
Q1 | $418K | Sell |
180,143
-26,005
| -13% | -$50.1K | 0.05% | 164 |
|
|
2022
Q4 | $369K | Sell |
206,148
-12,099
| -6% | -$24K | 0.04% | 173 |
|
|
2022
Q3 | $567K | Buy |
218,247
+4,997
| +2% | +$16.1K | 0.13% | 129 |
|
|
2022
Q2 | $610K | Sell |
213,250
-5
| -0% | -$22 | 0.08% | 126 |
|
|
2022
Q1 | $1.73M | Sell |
213,255
-5,600
| -3% | -$44K | 0.19% | 77 |
|
|
2021
Q4 | $1.75M | Sell |
218,855
-6,972
| -3% | -$69.4K | 0.22% | 95 |
|
|
2021
Q3 | $2.69M | Buy |
225,827
+1
| +0% | +$14 | 0.37% | 53 |
|
|
2021
Q2 | $3.5M | Buy |
225,826
+2,649
| +1% | +$44.6K | 0.42% | 46 |
|
|
2021
Q1 | $5.36M | Buy |
223,177
+16,000
| +8% | +$449K | 0.51% | 41 |
|
|
2020
Q4 | $6.11M | Buy |
207,177
+64,704
| +45% | +$1.41M | 0.82% | 25 |
|
|
2020
Q3 | $2.18M | Buy |
142,473
+10,298
| +8% | +$194K | 0.35% | 58 |
|
|
2020
Q2 | $3.3M | Buy |
132,175
+617
| +0.5% | +$13.4K | 0.53% | 40 |
|
|
2020
Q1 | $2.68M | Hold |
131,558
| – | – | 0.51% | 43 |
|
|
2019
Q4 | $4.07M | Buy |
131,558
+50
| +0% | +$1.62K | 0.62% | 34 |
|
|
2019
Q3 | $4.39M | Buy |
131,508
+17,384
| +15% | +$558K | 0.71% | 26 |
|
|
2019
Q2 | $3.65M | Sell |
114,124
-471
| -0.4% | -$15K | 0.61% | 33 |
|
|
2019
Q1 | $3.29M | Sell |
114,595
-3,118
| -3% | -$109K | 0.56% | 37 |
|
|
2018
Q4 | $4.73M | Buy |
117,713
+28,880
| +33% | +$1.09M | 0.89% | 17 |
|
|
2018
Q3 | $4.15M | Buy |
88,833
+3,327
| +4% | +$232K | 0.67% | 24 |
|
|
2018
Q2 | $7.04M | Buy |
85,506
+6,480
| +8% | +$437K | 1.16% | 9 |
|
|
2018
Q1 | $3.29M | Buy |
79,026
+6,491
| +9% | +$242K | 0.5% | 41 |
|
|
2017
Q4 | $2.36M | Hold |
72,535
| – | – | 0.37% | 60 |
|
|
2017
Q3 | $1.28M | Sell |
72,535
-72
| -0.1% | -$841 | 0.21% | 107 |
|
|
2017
Q2 | $762K | Sell |
72,607
-238
| -0.3% | -$2.53K | 0.12% | 162 |
|
|
2017
Q1 | $1.03M | Buy |
72,845
+20,000
| +38% | +$272K | 0.17% | 132 |
|
|
2016
Q4 | $608K | Sell |
52,845
-2,882
| -5% | -$39.5K | 0.1% | 180 |
|
|
2016
Q3 | $619K | Sell |
55,727
-414
| -0.7% | -$4.54K | 0.11% | 178 |
|
|
2016
Q2 | $657K | Hold |
56,141
| – | – | 0.11% | 159 |
|
|
2016
Q1 | $595K | Buy |
56,141
+9,605
| +21% | +$93K | 0.1% | 172 |
|
|
2015
Q4 | $447K | Sell |
46,536
-12,450
| -21% | -$141K | 0.08% | 213 |
|
|
2015
Q3 | $631K | Sell |
58,986
-184
| -0.3% | -$2.65K | 0.11% | 164 |
|
|
2015
Q2 | $1.06M | Hold |
59,170
| – | – | 0.16% | 125 |
|
|
2015
Q1 | $872K | Buy |
59,170
+2,000
| +3% | +$31.5K | 0.13% | 146 |
|
|
2014
Q4 | $760K | Sell |
57,170
-28,001
| -33% | -$439K | 0.12% | 167 |
|
|
2014
Q3 | $1.52M | Buy |
85,171
+7,655
| +10% | +$136K | 0.25% | 81 |
|
|
2014
Q2 | $1.4M | Buy |
77,516
+310
| +0.4% | +$5.62K | 0.22% | 94 |
|
|
2014
Q1 | $1.41M | Buy |
77,206
+5,000
| +7% | +$94.6K | 0.24% | 81 |
|
|
2013
Q4 | $1.21M | Sell |
72,206
-4,825
| -6% | -$81.6K | 0.22% | 92 |
|
|
2013
Q3 | $1.39M | Hold |
77,031
| – | – | 0.27% | 72 |
|
|
2013
Q2 | $1.56M | Buy |
+77,031
| New | +$1.49M | 0.28% | 69 |
|
Other funds holding CASI
VA
WP
Wellington Shields Capital Management's CASI Position: Q4 2025 in Review
Wellington Shields Capital Management sold out of CASI Pharmaceuticals (CASI) in Q4 2025, closing a stake of 69,535 shares — an estimated $115K sold.
Wellington Shields Capital Management first reported a position in CASI in Q2 2013 and held it in 50 quarters. The position peaked at $7.04M in Q2 2018. 16 funds tracked by Wall St. Rank hold CASI as of Q4 2025.
- Wellington Shields Capital Management reported no remaining CASI Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
- Wellington Shields Capital Management sold 69,535 CASI Pharmaceuticals shares in Q4 2025, an estimated $115K.
- Wellington Shields Capital Management first reported a position in CASI Pharmaceuticals in Q2 2013 and held it in 50 quarters.
- Wellington Shields Capital Management's CASI Pharmaceuticals position peaked at $7.04M in Q2 2018.
- 16 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q4 2025.
Based on Wellington Shields Capital Management's 13F filing for Q4 2025, filed 9 Feb 2026.